197 related articles for article (PubMed ID: 38375508)
1.
Swaidan NT; Soliman NH; Aboughalia AT; Darwish T; Almeshal RO; Al-Khulaifi AA; Taha RZ; Alanany R; Hussein AY; Salloum-Asfar S; Abdulla SA; Abdallah AM; Emara MM
Front Mol Biosci; 2024; 11():1342011. PubMed ID: 38375508
[TBL] [Abstract][Full Text] [Related]
2. Continuous expression of reprogramming factors induces and maintains mouse pluripotency without specific growth factors and signaling inhibitors.
Mao Y; Wang L; Zhong B; Yang N; Li Z; Cui T; Feng G; Li W; Zhang Y; Zhou Q
Cell Prolif; 2021 Aug; 54(8):e13090. PubMed ID: 34197016
[TBL] [Abstract][Full Text] [Related]
3. miR-524-5p of the primate-specific C19MC miRNA cluster targets TP53IPN1- and EMT-associated genes to regulate cellular reprogramming.
Nguyen PNN; Choo KB; Huang CJ; Sugii S; Cheong SK; Kamarul T
Stem Cell Res Ther; 2017 Sep; 8(1):214. PubMed ID: 28962647
[TBL] [Abstract][Full Text] [Related]
4. Mechanism and Method for Generating Tumor-Free iPS Cells Using Intronic MicroRNA miR-302 Induction.
Lin SL; Ying SY
Methods Mol Biol; 2018; 1733():265-282. PubMed ID: 29435940
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming- and pluripotency-associated membrane proteins in mouse stem cells revealed by label-free quantitative proteomics.
Hao J; Li W; Dan J; Ye X; Wang F; Zeng X; Wang L; Wang H; Cheng Y; Liu L; Shui W
J Proteomics; 2013 Jun; 86():70-84. PubMed ID: 23615220
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome profile of bovine iPSCs derived from Sertoli Cells.
Jiang Y; An XL; Yu H; Cai NN; Zhai YH; Li Q; Cheng H; Zhang S; Tang B; Li ZY; Zhang XM
Theriogenology; 2020 Apr; 146():120-132. PubMed ID: 31771794
[TBL] [Abstract][Full Text] [Related]
7. Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?
Boué S; Paramonov I; Barrero MJ; Izpisúa Belmonte JC
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862250
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming and differentiation-dependent transcriptional alteration of DNA damage response and apoptosis genes in human induced pluripotent stem cells.
Shimada M; Tsukada K; Kagawa N; Matsumoto Y
J Radiat Res; 2019 Nov; 60(6):719-728. PubMed ID: 31665364
[TBL] [Abstract][Full Text] [Related]
9. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
[TBL] [Abstract][Full Text] [Related]
10. Defining differentially methylated regions specific for the acquisition of pluripotency and maintenance in human pluripotent stem cells via microarray.
He W; Kang X; Du H; Song B; Lu Z; Huang Y; Wang D; Sun X; Yu Y; Fan Y
PLoS One; 2014; 9(9):e108350. PubMed ID: 25250679
[TBL] [Abstract][Full Text] [Related]
11. Pkm2 can enhance pluripotency in ESCs and promote somatic cell reprogramming to iPSCs.
Qin S; Yang D; Chen K; Li H; Zhang L; Li Y; Le R; Li X; Gao S; Kang L
Oncotarget; 2017 Oct; 8(48):84276-84284. PubMed ID: 29137422
[TBL] [Abstract][Full Text] [Related]
12. MiR-302-Mediated Somatic Cell Reprogramming and Method for Generating Tumor-Free iPS Cells Using miR-302.
Lin SL; Chen JS; Ying SY
Methods Mol Biol; 2020; 2115():199-219. PubMed ID: 32006403
[TBL] [Abstract][Full Text] [Related]
13. Combined Noncoding RNA-mRNA Regulomics Signature in Reprogramming and Pluripotency in iPSCs.
Salloum-Asfar S; Abdulla SA; Taha RZ; Thompson IR; Emara MM
Cells; 2022 Nov; 11(23):. PubMed ID: 36497092
[TBL] [Abstract][Full Text] [Related]
14. Concise review: induced pluripotency by defined factors: prey of oxidative stress.
Qi S; Fang Z; Wang D; Menendez P; Yao K; Ji J
Stem Cells; 2015 May; 33(5):1371-6. PubMed ID: 25594616
[TBL] [Abstract][Full Text] [Related]
15. Serum starvation-induced cell cycle synchronization stimulated mouse rDNA transcription reactivation during somatic cell reprogramming into iPSCs.
Zhao Q; Wu Y; Shan Z; Bai G; Wang Z; Hu J; Liu L; Li T; Shen J; Lei L
Stem Cell Res Ther; 2016 Aug; 7(1):112. PubMed ID: 27515169
[TBL] [Abstract][Full Text] [Related]
16. Positioning canine induced pluripotent stem cells (iPSCs) in the reprogramming landscape of naïve or primed state in comparison to mouse and human iPSCs.
Menon DV; Bhaskar S; Sheshadri P; Joshi CG; Patel D; Kumar A
Life Sci; 2021 Jan; 264():118701. PubMed ID: 33130086
[TBL] [Abstract][Full Text] [Related]
17. CXCR2 Ligands and mTOR Activation Enhance Reprogramming of Human Somatic Cells to Pluripotent Stem Cells.
Lee SJ; Kang KW; Kim JH; Lee BH; Jung JH; Park Y; Hong SC; Kim BS
Stem Cells Dev; 2020 Feb; 29(3):119-132. PubMed ID: 31808362
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional Factors Mediated Reprogramming to Pluripotency.
Fatima N; Saif Ur Rahman M; Qasim M; Ali Ashfaq U; Ahmed U; Masoud MS
Curr Stem Cell Res Ther; 2024; 19(3):367-388. PubMed ID: 37073151
[TBL] [Abstract][Full Text] [Related]
19. Generation of mice derived from induced pluripotent stem cells.
Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK
J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420
[TBL] [Abstract][Full Text] [Related]
20. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
